The wide variety of naturally occurring aminoglycoside antibiotics and the ready accessibility of chemically modified derivatives have permitted development of a reasonably detailed picture of structureactivity relationships within this important family of antibiotics. It appears from comparison of antibacterial properties of, for instance, kanamycins A, B and C, that the number and location of amino groups in the sugar portions attached to the deoxystreptamine nucleus, have a profound effect on the potency of these drugs').
Concerning the amino group of the aglycone it is well established that the 3-amino function is essential for antimicrobial activity and may neither be functionalized nor removed 2).
In contrast, it is also known that the 1-amino group can be acylated or alkylated to yield compounds with an improved spectrum of activity particularly against resistant strains3-7).
In continuation of our work on the synthesis of the pseudo-disaccharide 1-deaminotobramine, which is devoid of antibacterial activity5), we decided to extend this interesting biological observation to a genuine aminoglycoside.
In this paper we report the synthesis of 1-deaminogentamicin C2 (7) and its antibacterial properties in comparison with its parent gentamicin C2. Our synthetic approach was based on a radical induced deamination described by BARTON et al.'). Due to the low regioselectivity already observed for this reaction with unprotected aminoglycosides10), we required a fully N-protected gentamicin C2 intermediate 2 having only the 1-amino group free for the projected reactions' scheme.
The intermediate 2 was synthesized from the readily available 3,2',6'-tris-N-tert-butoxycarbonylgentamicin C211) in a one-pot reaction via selective benzyloxycarbonylation at N-1, followed by tert- O-deacetylation and N-deprotection, the target molecule 7 was isolated at its hydrochloride salt.
The chemical ionization mass spectrum13) ( Table 1 ) of 7 as free base (using isobutane as reagent gas) exhibits a parent ion peak MH+ at m/z 449 and a significant peak at m/z 307 resulting from the loss of the purpurosaminyl ring; the corresponding ion peaks for the parent gentamicin C2 (1) , are observed at rnlz 464 and m/z 322 respectively. These data confirm the absence of the 1-amino group in 7 . The Table 1 . Chemical ionization mass spectrum of gentamicin C2 (1) and 1-deaminogentamicin C Intensities (%) are shown in parentheses. comparison of 13C NMR data of 7 and I (Table 2) The in vitro antimicrobial activity of 7, in comparison with gentamicin C2, is shown in Table   3 . The ability of some major aminoglycoside inactivating enzymes to modify 1-deaminogentamicin C2 (7) was examined14,15). The results shown in Table 4 
Experimental
Melting points were determined on a Reichert hot-plate apparatus and are uncorrected. Optical rotations were measured on a "Quick" Roussel and Jouan polarimeter. IR spectra were recorded on a Perkin-Elmer 297 spectrometer. 1H NMR spectra were recorded on Varian T60 or EM 360L (60 MHz) instruments and 113C NMR on Bruker WP-60 (15.08 MHz) or HX-90 (22.63 MHz), chemical shifts (5) are reported with reference to tetramethylsilane.
Mass spectra were recorded on either an A. E. I. MS-9 or an A. E. 1. MS-50 spectrometer. TLC was performed on Schleicher and Schiill plastic backed . A value of 100% of inactivation was assigned to gentamicin C1a . b The substrates of the enzymatic reactions were gentamicin C., with AAC (3) , AAC (2') and APH (2") and gentamicin Cl with AAC (6'). AAC: Aminoglycoside acetyltransferase.
APH: aminoglycoside phosphotransferase.
silica gel plates (F 1500 S 254); the plates were initially examined under UV light (254 and 366 nm) then developed with appropriate spray reagents. Column chromatography was effected, under low pressure, using Merck Kielselgel (Type 60) and the eluant given in parentheses. Evaporations were carried out at below 40°C using a Btichi rotary evaporator. The microanalyses were performed by the analytical department of the I.C.S.N., Gif-sur-Yvette.
3,2',6',3"-Tetrakis-N-tert-butoxycarbonylgentamicin C2 (2) To a solution of 3,2',6'-tris-N-tert-butoxycarbonylgentamicin C211) (4.34 g) in dichloromethane/ methanol (50 ml/2.5 ml) was added dropwise a solution of N-benzyloxycarbonyloxyphtalimide (1.77 g) in dichloromethane/methanol (10 ml/l ml) at room temperature.
After stirring for 2 hours the mixture was extracted with aqueous saturated sodium hydrogen carbonate solution until the red color disappeared. To the organic layer was added di-tert-butyl dicarbonate (1.8 g) and pyridine (0.5 ml). This solution was stirred at room temperature overnight and then extracted twice with 10% aqueous ammonium hydroxide. The solvent was removed, the residue dissolved in methanol/water (30 ml/3 ml) and ammonium formate (2.3 g) and palladium (10% on charcoal) was added. The mixture was refluxed for 1 hour. Removal of the catalyst and the solvent followed by extraction with dichloromethanewater and chromatography on a silica gel column using dichloromethane -methanol (15: 1) as the eluant yielded 2 as an amorphous solid (3.67 g, 75 % yield).
3,2',6',3"-Tetrakis-N-tert-butoxycarbonyl-l-N-formylgentamicin C2 (3) A solution of 2 (1 g) and p-nitrophenyl formate (970 mg) in dioxane (15 ml) was stirred at room temperature overnight. After evaporation of the solvent in vacuo, the residue was chromatographed on a silica gel column using a dichloromethane -methanol -concentrated ammonium hydroxide solution 1 g) in anhydrous pyridine (20 ml) was added at 0°C, p-toluenesulfonyl chloride (570mg).
The resulting mixture was stirred for 24 hours and then poured into an ice-cooled aqueous solution of sodium hydrogen carbonate. The crude solid was purified by column chromatography on silica gel (dichloromethane -ethanol, 23 :2). After recrystallization from chloroform -ether, the compound 5 was isolated as white needles (690 mg, 70% yield); mp 157 159°C, [a]~° -i 32° (c 1, CH2Cl2), IR 2140 cm-1 (isonitrile), 1H NMR (CDCl3) no signal at 5 7.8.
Anal. Calcd. for C"H;;N,O,: C 53.68, H 7.76, N 7.00 Found: C 53.49, H 7.81, N 7.07 5,2",4"-Tri-O-acetyl-3,2',6',3"-tetrakis-N-tert-butoxycarbonyl-l-deaminogentamicin C2 (6) A solution of the isocyanide 5 (500 mg) and azobisisobutyronitrile (AIBN) (30 mg) in dry benzene (20 ml) was added dropwise to a refluxing solution of tri-n-butylstannane (1 g) in benzene (25 ml) under nitrogen.
Heating was maintained for 3 hours. Removal of the solvent and column chromatography on silica gel (dichloromethane -ethanol, 23 : 2) provided 6 which was recrystallized from chloroform - 1-Deaminogentamicin C2 (7) To a solution of 6 (200 mg) in dry methanol (7 ml) was added a 1 M methanolic sodium methoxide (1 ml). After stirring for 2 hours, the solution was neutralized by addition of Amberlite IRC-50 (H+) resin. The resin was filtered off and the filtrate concentrated in vacuo. The residue (165 mg) was dissolved in trifluoroacetic acid (4 m]). To the stirred solution, after 2 minutes, ether was added to precipitate the salt. The latter was isolated by filtration and deionized with Amberlite IR-45 (OH-) resin. The aqueous solution containing the free base 7 was lyophilized and then dissolved in methanol. The resulting solution was acidified with 1 M hydrochloric acid (pH 3) and then poured into a ice-cold vigorously stirred ether (40 ml). Enzyme Preparation Bacteria were grown in Trypticase Soy Broth (Merieux) in the presence of 20 tig/ml of an aminoglycoside to which there were resistant. The cells were harvested at the late logarithmic phase and washed twice with buffer A: 10 mm tris-HCI pH 7.5, 10 mm MgCl2,20 mM NH4Cl, 6 mM (3-mercaptoethanol. They were then resuspended in the same buffer (15 ml/g of wet cells) and either submitted to sonication at 4°C (four 30 seconds bursts at 100 W out put, separated by 2 minutes cooling periods) or disrupted by passage through a French pressure cell at 1 kg/cm2. In the case of Staphylococcus aureus, the washed cells were resuspended in 100 mm NaCl, 20 mm tris-HCl buffer pH 7.5 (25 ml/g). The suspension was stirred gently for 1 hour at 37°C in the presence of lysostaphin (0.5 mg/g of bacteria) and then DNase (4 big/ml) was added and Mg2+ and NH4+ concentrations were adjusted to 10 and 20 mm respectively before centrifugation at 20,000 x g for 20 minutes at +4°C. Cell free extracts were obtained by centrifugation at 200,000 x g for 2 hours and then submitted to electrofocusing or to affinity chromatography on immobilized aminoglycoside15,17)Crude as well as purified enzymes were stored in liquid nitrogen in 500,ul portions.
Enzymatic Assays Standard phosphocellulose binding assay was used"). Each assay contained 5 µl of 2 mm antibiotic solution, 5 /Il of labelled donor (14C AcCoA: 2.5 mm, 2 Ci/mole; 732P GTP: 2 mm, 2.5 Ci/mole), 40 111 of purified enzyme solution in buffer A. The mixture was incubated at 37°C for generally 10 minutes. The inhibition of inactivation of gentamicin C2 by the 1-deaminogentamicin C2 (7) was done as described above; to the previous mixtures were added either 5 111 of 2 mm solution of 7 or 5 111 of water for the reference experiments.
